The present invention provides a compound of formula (I) wherein A is an optionally
substituted C1-4alkylidene group or a bond, R20 and R21
are hydrogen, alkyl groups or heterocyclic groups, R1 and R2
are small substituents or hydrogen, L is O, S or substituted N, X is a 5-
or 6-membered heteroaromatic ring, Y is C1-4alkylidene and Z is a 5-
or 6-membered heteroaromatic ring; or a pharmaceutically acceptable salt thereof;
pharmaceutical compositions comprising it; its use in therapy; its use in making
medicaments for treating neurodegenerative disease and methods of using it to enhance cognition.